Clinical Trial Update: Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

View source ↗

Summary

Phase 2 study of JNJ-53718678 in adults and adolescents with RSV infection after hematopoietic stem cell transplantation was terminated. Results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• JNJ-53718678

Snippet

Sponsor: Janssen Sciences Ireland UC | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: TERMINATED | Results posted: 2023-04-14